Medifast
MED
223 hedge funds and large institutions have $724M invested in Medifast in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 72 increasing their positions, 84 reducing their positions, and 42 closing their positions.
1.61% less ownership
Funds ownership: 88.79% → 87.19% (-1.6%)
6% less funds holding
Funds holding: 236 → 223 (-13)
14% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 84
19% less capital invested
Capital invested by funds: $892M → $724M (-$168M)
31% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 42
77% less call options, than puts
Call options by funds: $8.82M | Put options by funds: $39.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$7.01M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$6.62M |
| 3 |
Renaissance Technologies
New York
|
+$6.53M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$6.46M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$6.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
-$13.3M |
| 2 |
Morgan Stanley
New York
|
-$11.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.12M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$5.88M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$5.78M |
MED Hedge Fund Activity: Q3 2023 in Review
223 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q3 2023, worth a combined $724M — down 19% from $892M a quarter earlier.
Sellers outnumbered buyers: 42 funds closed out of MED and 29 opened new positions — a net loss of 13 holders — while 84 trimmed existing stakes and 72 added.
The largest buyer was Pacer Advisors, adding an estimated $7.01M. The largest seller was Man Group, exiting entirely with an estimated $13.3M sold.
- 223 institutional investors held Medifast (MED) as of Q3 2023, down from 236 in Q2 2023.
- Funds reported $724M of Medifast stock for Q3 2023, down 19% quarter-over-quarter.
- 29 funds opened new Medifast positions in Q3 2023 and 42 closed out, a net change of -13 holders.
- The largest Medifast buyer in Q3 2023 was Pacer Advisors, an estimated $7.01M added.
- The largest Medifast seller in Q3 2023 was Man Group, an estimated $13.3M sold.
Based on aggregated 13F filings for Q3 2023.